Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immune responses to influenza virus infection.
Kreijtz JH, Fouchier RA, Rimmelzwaan GF. Kreijtz JH, et al. Virus Res. 2011 Dec;162(1-2):19-30. doi: 10.1016/j.virusres.2011.09.022. Epub 2011 Sep 22. Virus Res. 2011. PMID: 21963677 Review.
Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
van de Sandt CE, Kreijtz JH, Geelhoed-Mieras MM, Vogelzang-van Trierum SE, Nieuwkoop NJ, van de Vijver DA, Fouchier RA, Osterhaus AD, Morein B, Rimmelzwaan GF. van de Sandt CE, et al. Among authors: kreijtz jh. Vaccine. 2014 Sep 29;32(43):5614-23. doi: 10.1016/j.vaccine.2014.08.003. Epub 2014 Aug 17. Vaccine. 2014. PMID: 25140929
Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases.
Altenburg AF, Kreijtz JH, de Vries RD, Song F, Fux R, Rimmelzwaan GF, Sutter G, Volz A. Altenburg AF, et al. Among authors: kreijtz jh. Viruses. 2014 Jul 17;6(7):2735-61. doi: 10.3390/v6072735. Viruses. 2014. PMID: 25036462 Free PMC article. Review.
Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccine.
de Vries RD, De Gruyter HL, Bestebroer TM, Pronk M, Fouchier RA, Osterhaus AD, Sutter G, Kreijtz JH, Rimmelzwaan GF. de Vries RD, et al. Among authors: kreijtz jh. Emerg Infect Dis. 2015 Jun;21(6):1086-8. doi: 10.3201/eid2106.150021. Emerg Infect Dis. 2015. PMID: 25988813 Free PMC article. No abstract available.
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.
de Vries RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, van Trierum SE, Pronk MR, Lamers MM, Richard M, Nieuwenhuijse DF, Koopmans MPG, Kreijtz JHCM, Fouchier RAM, Osterhaus ADME, Sutter G, Rimmelzwaan GF. de Vries RD, et al. Among authors: kreijtz jhcm. J Infect Dis. 2018 Jul 13;218(4):614-623. doi: 10.1093/infdis/jiy214. J Infect Dis. 2018. PMID: 29912453 Free PMC article. Clinical Trial.
Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.
van de Sandt CE, Kreijtz JH, Geelhoed-Mieras MM, Nieuwkoop NJ, Spronken MI, van de Vijver DA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. van de Sandt CE, et al. Among authors: kreijtz jh. J Virol. 2015 Nov 4;90(2):1009-22. doi: 10.1128/JVI.02439-15. Print 2016 Jan 15. J Virol. 2015. PMID: 26537686 Free PMC article.
Heterosubtypic immunity to H7N9 influenza virus in isogenic guinea pigs after infection with pandemic H1N1 virus.
Wiersma LC, Vogelzang-van Trierum SE, Kreijtz JH, van Amerongen G, van Run P, Ladwig M, Banneke S, Schaefer H, Fouchier RA, Kuiken T, Osterhaus AD, Rimmelzwaan GF. Wiersma LC, et al. Among authors: kreijtz jh. Vaccine. 2015 Dec 8;33(49):6977-82. doi: 10.1016/j.vaccine.2015.08.038. Epub 2015 Aug 25. Vaccine. 2015. PMID: 26319067
Virus replication kinetics and pathogenesis of infection with H7N9 influenza virus in isogenic guinea pigs upon intratracheal inoculation.
Wiersma LC, Kreijtz JH, Vogelzang-van Trierum SE, van Amerongen G, van Run P, Ladwig M, Banneke S, Schaefer H, Fouchier RA, Kuiken T, Osterhaus AD, Rimmelzwaan GF. Wiersma LC, et al. Among authors: kreijtz jh. Vaccine. 2015 Dec 8;33(49):6983-7. doi: 10.1016/j.vaccine.2015.08.050. Epub 2015 Aug 22. Vaccine. 2015. PMID: 26307235
Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis.
Ramezanpour B, Pronker ES, Kreijtz JH, Osterhaus AD, Claassen E. Ramezanpour B, et al. Among authors: kreijtz jh. Vaccine. 2015 Aug 20;33(35):4349-58. doi: 10.1016/j.vaccine.2015.04.086. Epub 2015 Jun 3. Vaccine. 2015. PMID: 26048779 Free PMC article.
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial.
Kreijtz JH, Goeijenbier M, Moesker FM, van den Dries L, Goeijenbier S, De Gruyter HL, Lehmann MH, Mutsert Gd, van de Vijver DA, Volz A, Fouchier RA, van Gorp EC, Rimmelzwaan GF, Sutter G, Osterhaus AD. Kreijtz JH, et al. Lancet Infect Dis. 2014 Dec;14(12):1196-207. doi: 10.1016/S1473-3099(14)70963-6. Epub 2014 Oct 30. Lancet Infect Dis. 2014. PMID: 25455987 Clinical Trial.
40 results
Jump to page
Feedback